No takes yet. Share an insight, caveat, or question.
Ivabradine's clinical applications are evolving based on its mechanism of selectively inhibiting the funny current.
Koruth et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: